subject have significantly impair hepatic function at screening visit 1 or randomization visit 2 alanine aminotransferase alt 5 x upper limit of normal uln or total bilirubin tbl 2 x uln or the alt or aspartate aminotransferase ast 3 x uln and tbl 2 x uln or international normalized ratio 1.5 this criterion can only be confirm once the laboratory result be available subject randomize into the study who be late found not to meet this criterion should be withdraw from the study 